Immuneering CorporationIMRXNASDAQ
Loading
Stockholders Equity Over TimeExpanding
Percentile Rank100
3Y CAGR+25.8%
Studio
Year-over-Year Change

Net worth of the company (assets minus liabilities)

3Y CAGR
+25.8%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
2x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$218.48M+427.9%
2024$41.39M-54.3%
2023$90.58M-17.5%
2022$109.85M-29.6%
2021$155.98M+793.8%
2020$-22.48M-244.4%
2019$-6.53M-